Neogenomics Inc (NASDAQ:NEO)
| 53.49 Delayed Data As of 4:00pm ET |  -1.44 / -2.62%Today’s Change | 20.47 Today|||52-Week Range 57.91 | -0.65% Year-to-Date |
Latest NEO News | Press Releases
No recent news for Neogenomics Inc.
Today’s Trading
| Previous close | 54.93 |
| Today’s open | 57.30 |
| Day’s range | 51.37 - 55.22 |
| Volume | 61,642 |
| Average volume (3 months) | 787,140 |
| Market cap | $6.5B |
Data as of 4:00pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +12.10% |
| Earnings growth (this year) | -76.86% |
| Earnings growth (next 5 years) | +50.79% |
| Revenue growth (last year) | +47.73% |
| P/E ratio | NM |
| Price/Sales | 7.41 |
| Price/Book | 11.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVTAInvitae Corp | -0.85 | -1.77% |
| NTRANatera Inc | -9.74 | -8.89% |
| ---- | ||
| FLGTFulgent Genetics Inc | +9.51 | +12.60% |
Data as of 4:52pm ET, 01/27/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $408.8M |
| Annual profit (last year) | $8.0M |
| Net profit margin | 1.96% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Fort Myers, Florida |
Forecasts
